Globally the COVID-19 caseload has topped 188.9 million, while the deaths have surged to more than 4.07 million and vaccinations soared to over 3.56 billion, according to the Johns Hopkins University.
COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
‘The US continues to be the worst-hit country with the world's highest number of COVID cases and deaths at 334,051,023 and 608,809, respectively, according to the CSSE.’
In terms of infections, India follows in the second place with 31,026,829 cases. The other worst countries with over 3 million cases are Brazil (19,308,109), France (5,906,421), Russia (5,835,523), Turkey (5,507,455), the UK (5,353,240), Argentina (4,737,213), Colombia (4,601,335), Italy (4,281,214), Spain (4,100,222), Germany (3,749,944) and Iran (3,485,940), the CSSE figures showed.
In terms of deaths, Brazil comes second with 540,398 fatalities.
COVID-19: Diet Plan and Lifestyle Modifications for the Unlock Phase
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.
Source-IANS
Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
Green Fungus or Aspergillosis and COVID-19 Infection
Green fungus or Aspergillosis is caused by a common mold, which exists both indoors and outdoors. Every day, people inhale Aspergillus spores, but it isn't harmful. However, it affects people who have a weak immune system. If the infection is left untreated, it can cause pneumonia.
Green fungus or Aspergillosis is caused by a common mold, which exists both indoors and outdoors. Every day, people inhale Aspergillus spores, but it isn't harmful. However, it affects people who have a weak immune system. If the infection is left untreated, it can cause pneumonia.
